As of Jul 31
| +0.06 / +0.28%|
The 2 analysts offering 12-month price forecasts for Albany Molecular Research Inc have a median target of 22.50, with a high estimate of 23.00 and a low estimate of 22.00. The median estimate represents a +6.43% increase from the last price of 21.14.
The current consensus among 3 polled investment analysts is to Buy stock in Albany Molecular Research Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.